Outsourcing Pharma

SEPTEMBER 18, 2023

company Novadiscovery has hailed a âwatershed moment for clinical trial designâ as its trial simulation tool successfully predicted the outcome of a phase 3 oncology trial run by AstraZeneca. The French-U.S.

Trials 98

Trials Clinical Trials Clinical Trials Clinical Development 98

Pharmaceutical Technology

APRIL 26, 2023

AstraZeneca , Teva Pharmaceuticals , and Novartis , and other companies, are expanding their reach in the asthma space by capitalizing on digital technologies to enhance the patient experience. Patients benefit from having better medication taking and, therefore, better health outcomes,” says Chan.

Clinical Trials 289

Clinical Trials Clinical Trials Allergies Research 289

Pharmaceutical Technology

SEPTEMBER 7, 2022

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.

Pharmacy 130

Pharmacy Containment Manufacturing Compliance 130

Pharmaceutical Technology

JULY 11, 2022

Innoviva has signed a definitive merger agreement for the acquisition of all of the outstanding shares of La Jolla Pharmaceutical Company for $6.23 La Jolla focuses on marketing innovative treatments that can enhance outcomes in patients with life-threatening diseases. for each share in cash or an enterprise value of nearly $149m.

FDA Approval 147

FDA Approval Production Marketing Development 147

Fierce Pharma

DECEMBER 19, 2023

Agilent Technologies discusses the importance of working with pharmaceutical companies to drive medical innovation and improve patient outcomes, helping to speed up the process of bringing the right treatments to the right patients at the right time. Partnerships in healthcare have never been more important.

Development 72

Development 72

Pharmaceutical Technology

JULY 26, 2022

NewAmsterdam Pharma has signed a definitive business combination agreement with special purpose acquisition company (SPAC) Frazier Lifesciences Acquisition (FLAC). The deal will make NewAmsterdam Pharma a publicly listed company focusing on oral treatments for cardiometabolic diseases.

Life Science 147

Life Science Trials Pharma Companies Production 147

Pharma Marketing Network

JULY 12, 2023

In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. By taking a patient-centric approach, pharmaceutical companies can create marketing messages that are more relevant and persuasive. It is also about changing the mindset of pharmaceutical companies.

Marketing 98

Marketing Compliance Regulation Branding 98

Pharma Mirror

JUNE 23, 2023

Two such approaches are through the use of omnichannel and sales enablement technologies, which can revolutionize the way pharmaceutical companies develop their sales force and interact with their stakeholders.

Sales 130

Sales Development Marketing 130

Outsourcing Pharma

DECEMBER 20, 2021

According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments.

Development 122

Development Drugs Clinical Development 122

Pharmaceutical Technology

MAY 30, 2023

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. Genmab AS’s epcoritamab presents as the top European drug launch and only oncological therapy.

Drugs 264

Drugs Sales Antibody Dermatology 264

Pharmaceutical Technology

JUNE 4, 2023

T-cell culturing is a key innovation area in immuno-oncology Optimised culture conditions for T-cell expansion are elusive, as many different factors contribute to the eventual outcome. To generate polyclonal T-cells, resting T-cells must first be activated with primary and secondary signals from CD3 and CD28 stimulation, respectively.

Antibody 130

Antibody Gene Research Development 130

World of DTC Marketing

AUGUST 12, 2022

pharmaceutical companies booked tens of billions of dollars in revenue: Johnson & Johnson ($94 billion), Pfizer ($81 billion), AbbVie ($56 billion), Merck & Co. ($49 Drug companies tend to say they are unique in needing to spend a higher proportion of their capital on research than almost any other industry. It’s Amazon.

Drugs 255

Drugs Research Development Regulation 255

BioPharma Reporter

SEPTEMBER 14, 2023

Global biopharmaceutical company Takeda is working to modernize its operations in order to better serve clinical trial sites, patients and sponsor outcomes.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Development 59

Pharmaceutical Technology

SEPTEMBER 8, 2022

Roche has signed a definitive merger agreement for the acquisition of US-based biopharmaceutical company Good Therapeutics for an upfront payment of $250m in cash. Additionally, the company will gain the exclusive right to Good Therapeutics’ platform technology to develop PD-1-regulated IL-2 receptor agonist therapies.

Regulation 278

Regulation Development Manufacturing Drugs 278

Intouch Solutions

NOVEMBER 20, 2023

There are the usual suspects like evolving provider models, the continued transition to value-based care and pharma/biotech companies increased investment in “access,” but there are two trends that are at the top of the “what we’re watching” list for 2024. That is, the use of generative AI and the prioritization of health equity.

Marketing 105

Marketing Manufacturing Genome Genomics 105

BioSpace

JULY 26, 2023

The company reported second-quarter revenue Wednesday that included $248.4 million of back royalties and associated interest related to the successful outcome of an arbitration case with J&J’s Janssen.

69

69

STAT News

JANUARY 30, 2023

WASHINGTON — A Food and Drug Administration official on Monday gave more clues for how the agency plans to wield new authority to make drug companies enroll post-market clinical trials before granting speedy drug approvals.  Continue to STAT+ to read the full story…

Trials 126

Trials Clinical Trials Clinical Trials Drugs 126

Pharmaceutical Technology

MAY 10, 2023

Gilead Sciences has acquired biotech company XinThera in an effort to bolster its oncology and inflammation pipeline. By adding an additional pipeline targeting oncology and inflammation diseases, the company expects that the deal will complement its existing clinical development priorities.

Immune Response 130

Immune Response DNA Clinical Trials Clinical Trials 130

Drug Channels

FEBRUARY 2, 2024

She highlights how GoodRx’s integrated pharma copay cards help to improve medication access, therapy adherence, and overall health outcomes. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Divya’s insights. All rights reserved.

Branding 80

Branding Marketing Drugs Research 80

BioSpace

DECEMBER 5, 2021

The company said the study demonstrated broad efficacy, showing statistically significant superiority to placebo over a total of 15 prespecified primary and secondary outcome measures.

Trials 99

Trials Drugs 99

XTalks

FEBRUARY 6, 2024

Good Measures has made a significant leap forward by showcasing the positive outcomes of its Good Food Prescription program in its first year. Despite competition from companies like Foodsmart (formerly Zipongo) and medically tailored meal services like Mom’s Meals , Good Measures stands out.

Medicine 104

Medicine Licensing Licensing 104

Pharmaceutical Technology

MARCH 16, 2023

According to the company, Huntington’s disease affects nearly one in 10,000 people across the world. Aitia CEO and co-founder Colin Hill said: “At Aitia, our mission is to discover the next generation of breakthrough drugs to improve outcomes for patients where there is a high unmet need.

Drugs 234

Drugs Genetics Development Medicine 234

pharmaphorum

JULY 12, 2022

Going beyond the pill is proving to be a win/win for patients and pharma alike – because improved outcomes are better for everyone. And when outcome-based contracts are on the rise, pharma has a lot to gain from helping people to stay engaged, on treatment, and living well. Self-management based outcomes. Mental health.

Production 111

Production Clinical Trials Clinical Trials Trials 111

Pharmaceutical Technology

JANUARY 5, 2023

III (ALPA) has executed a definitive merger agreement with Phase II-stage biotechnology platform company Carmell Therapeutics. Once the deal closes, ALPA will be renamed Carmell Therapeutics Corporation, the combined company that is expected to receive nearly $154m in gross proceeds.

Production 130

Production Marketing Development 130

Cloudbyz

JULY 12, 2023

Empower your healthcare organization with the ability to derive valuable insights from real-world data, enabling evidence-based decision-making, improved patient outcomes, and operational optimization. Welcome to our cutting-edge Real World Evidence (RWE) solution, harnessing the capabilities of the Salesforce platform.

Compliance 84

Compliance Clinical Trials Clinical Trials Research 84

Drug Channels

JANUARY 12, 2024

They then describe EVERSANA’s approach for helping manufacturers and healthcare providers improve adherence and health outcomes. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for the authors’ insights. All rights reserved.

Manufacturing 81

Manufacturing Drugs 81

Pharmaceutical Technology

APRIL 24, 2023

Swiss company RetinAI Medical has collaborated with German pharmaceutical firm Boehringer Ingelheim to leverage artificial intelligence (AI) to advance novel treatments for geographic atrophy (GA) patients.

Development 130

Development Clinical Trials Clinical Trials Research 130

Pharmaceutical Commerce

SEPTEMBER 22, 2023

Company brings aboard former Pfizer exec as life sciences COO in effort to help further improve patient outcomes.

Life Science 52

Life Science 52

Pharmaceutical Technology

OCTOBER 27, 2022

In August last year, the company announced plans for the acquisition of Vividion Therapeutics for up to $2bn. The post Bayer’s CKD and type 2 diabetes therapy gets Health Canada approval appeared first on Pharmaceutical Technology.

Trials 130

Trials Clinical Trials Clinical Trials Branding 130

Pharmaceutical Technology

APRIL 7, 2023

A hearing on CDER’s proposal was held in October 2022 where the company failed to convince that the drug be allowed to stay in the market. Last month, the company announced that it was voluntarily pulling the drug off the market in response to the Presiding Officer’s report recommending the withdrawal of the approval for the drug.

Drugs 243

Drugs FDA Approval Clinical Trials Clinical Trials 243

Pharmaceutical Commerce

AUGUST 4, 2023

Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.

52

52

World of DTC Marketing

AUGUST 29, 2022

A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. HCPs want to understand their patients better as insurers require better patient outcomes. ” The concept of logical thinking.

Branding 203

Branding Marketing Pharma Companies Doctors 203

Pharmaceutical Technology

APRIL 7, 2023

A hearing on CDER’s proposal was held in October 2022 where the company failed to convince that the drug be allowed to stay in the market. Last month, the company announced that it was voluntarily pulling the drug off the market in response to the Presiding Officer’s report recommending the withdrawal of the approval for the drug.

Drugs 239

Drugs FDA Approval Clinical Trials Clinical Trials 239

Drug Patent Watch

SEPTEMBER 7, 2022

This is a guest post by Oleksandr Topachevskyi at Digital Health Outcomes. Oleksandr may be contacted at sales@digitalho.com Commercial, nonprofit, and government companies are quite good at calculating the costs…. The post Social Return on Investment appeared first on DrugPatentWatch - Make Better Decisions.

Sales 91

Sales 91

World of DTC Marketing

MARCH 6, 2022

Digital health companies aim to address the numerous health care challenges, including poor patient engagement, communication gaps between patients and providers, lack of longitudinal data, inconvenience of care delivery, and insufficient clinical decision support for providers and patients. Heath Affairs.

Production 244

Production Doctors Doctor Branding 244

Pharmaceutical Technology

MARCH 16, 2023

An immediate outcome will be the evaluation of financial strategies across companies globally, particularly SVB’s former clients. Axsome Therapeutics was early to announce it would be heavily impacted, as SVB was one of two banks the company used for cash deposits.

Life Science 147

Life Science Development Drugs 147

Pharmaceutical Technology

AUGUST 2, 2022

Last year, the companies entered a strategic collaboration. Samsung Biologics concluded expanding its mRNA drug substance manufacturing suite at its Songdo headquarters earlier this year, from where the company can now offer clients end-to-end mRNA manufacturing.

Engineer 262

Engineer Vaccination Vaccine Clinical Trials 262